Figure 1From: Prospective single-arm study of 72 Gy hyperfractionated radiation therapy and combination chemotherapy for anaplastic astrocytomasOverall survival rates of the HFRT group. Three-year and 5-year overall survival rates were 64.8% and 60.8%, respectively.Back to article page